Who has invested in Accro Bioscience?

Morningside Ventures are named among the investors backing Accro Bioscience.

Accro Bioscience Funding: $100M Raised, Series C (2026)

Accro Bioscience funding overview

Accro Bioscience is based in Suzhou, China. Accro Bioscience has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2026. The round record for Accro Bioscience runs through 2026; nothing later has been disclosed. Investors on record include Morningside Ventures.

Accro Bioscience at a glance

Total raised: $100M
Latest round: Series C
Latest round date: May 2026
Headquarters: Suzhou, China
Notable investors: Morningside Ventures

Frequently asked about Accro Bioscience funding

How much has Accro Bioscience raised?: Accro Bioscience has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Accro Bioscience?: Morningside Ventures are named among the investors backing Accro Bioscience.
What was the latest Accro Bioscience funding round?: The most recent disclosed round is a Series C, announced in May 2026.
Where is Accro Bioscience based?: Accro Bioscience is based in Suzhou, China.
When did Accro Bioscience last raise?: The last disclosed Accro Bioscience round closed in May 2026 at Series C.

Totals shown for Accro Bioscience aggregate every disclosed round on file. To see how that compares, browse the companies in Suzhou and the investors behind them below.

Accro Bioscience Funding: $100M Raised, Series C (2026)

Accro Bioscience funding overview

Accro Bioscience at a glance

Frequently asked about Accro Bioscience funding

Companies related to Accro Bioscience (36)

Browse related funding lists (4)